Clinical Research Directory
Browse clinical research sites, groups, and studies.
Contrast-enhanced Spectral Mammography (CESM) Breast Cancer Screening
Sponsor: University of Virginia
Summary
The purpose of this study is to evaluate how well women may adopt a Contrast-enhanced Spectral Mammography (CESM) as their yearly breast screening test compared to the standard 2-D or 3-D mammogram.
Official title: Willingness of Women to Undergo a Contrast-enhanced Spectral Mammography (CESM) for Breast Cancer Screening and Their Experience Before and After CESM
Key Details
Gender
FEMALE
Age Range
40 Years - 69 Years
Study Type
INTERVENTIONAL
Enrollment
210
Start Date
2019-09-19
Completion Date
2023-06
Last Updated
2022-11-17
Healthy Volunteers
Yes
Conditions
Interventions
Contrast-enhanced spectral mammography (CESM)
CESM is a mammogram performed after the injection of IV contrast. CESM is used most often when additional information is needed after a standard mammogram. CESM has also been used to determine the extent of a known breast cancer, to screen patients at high risk for developing breast cancer due to a family history or positive cancer genes, and for women with dense breast tissue. Two images are taken almost at the same time during the exam, after the iodine based contrast injection is administered. The first image is comparable to a regular mammogram. The second image shows areas that take up the contrast (enhance) showing increased blood flow. Breast cancers often enhance with contrast due to a greater amount of blood vessels. Non-cancerous lesions can also have greater blood flow.
Locations (1)
UVA Breast Care Center
Charlottesville, Virginia, United States